Publications

Found 1 results
Filters: Author is D.R. Daga  [Clear All Filters]
2010
I. C. R. Santos, Daga, D. R., Frigeri, H. R., Réa, R. R., Almeida, A. C. R., Souza, E. M., Pedrosa, F. O., Fadel-Picheth, C. M. T., and Picheth, G., The functional polymorphisms -429T>C and -374T>A of the RAGE gene promoter are not associated with gestational diabetes in Euro-Brazilians, vol. 9. pp. 1130-1135, 2010.
Bierhaus A and Nawroth PP (2009). Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 52: 2251-2263. http://dx.doi.org/10.1007/s00125-009-1458-9 PMid:19636529   Bierhaus A, Humpert PM, Morcos M, Wendt T, et al. (2005). Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83: 876-886. http://dx.doi.org/10.1007/s00109-005-0688-7 PMid:16133426   Bucciarelli LG, Wendt T, Rong L, Lalla E, et al. (2002). RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol. Life Sci. 59: 1117-1128. http://dx.doi.org/10.1007/s00018-002-8491-x PMid:12222959   Dos Santos KG, Canani LH, Gross JL, Tschiedel B, et al. (2005). The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol. Genet. Metab. 85: 149-156. http://dx.doi.org/10.1016/j.ymgme.2005.02.010 PMid:15896660   Falcone C, Campo I, Emanuele E, Buzzi MP, et al. (2004). Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int. J. Mol. Med. 14: 1061-1064. PMid:15547674   Hudson BI, Stickland MH, Futers TS and Grant PJ (2001a). Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50: 1505-1511. http://dx.doi.org/10.2337/diabetes.50.6.1505 PMid:11375354   Hudson BI, Stickland MH, Grant PJ and Futers TS (2001b). Characterization of allelic and nucleotide variation between the RAGE gene on chromosome 6 and a homologous pseudogene sequence to its 5' regulatory region on chromosome 3: implications for polymorphic studies in diabetes. Diabetes 50: 2646-2651. http://dx.doi.org/10.2337/diabetes.50.12.2646 PMid:11723045   JiXiong X, BiLin X, MingGong Y and ShuQin L (2003). -429T/C and -374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care 26: 2696-2697.   Kankova K, Stejskalova A, Hertlova M and Znojil V (2005). Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol. Dial. Transplant. 20: 1093-1102. http://dx.doi.org/10.1093/ndt/gfh711 PMid:15790669   Kirbis J, Milutinovic A, Steblovnik K, Teran N, et al. (2004). The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes. Coll. Antropol. 28: 611-616. PMid:15666591   Lahiri DK and Nurnberger JI Jr (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19: 5444. http://dx.doi.org/10.1093/nar/19.19.5444 PMid:1681511 PMCid:328920   Langer O, Yogev Y, Xenakis EM and Brustman L (2005). Overweight and obese in gestational diabetes: the impact on pregnancy outcome. Am. J. Obstet. Gynecol. 192: 1768-1776. http://dx.doi.org/10.1016/j.ajog.2004.12.049 PMid:15970805   Lappas M, Permezel M and Rice GE (2007). Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J. Endocrinol. 193: 269- 277. http://dx.doi.org/10.1677/JOE-06-0081 PMid:17470518   Lindholm E, Bakhtadze E, Sjogren M, Cilio CM, et al. (2006). The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia 49: 2745-2755. http://dx.doi.org/10.1007/s00125-006-0412-3 PMid:16969646   NCBI (2009). Single nucleotide polymorphism (NCBI). Available at [http://www.ncbi.nlm.nih.gov/projects/SNP/ (search rs1800624 and rs1800625)]. Accessed December 10, 2009.   Nizard J and Ville Y (2009). The fetus of a diabetic mother: sonographic evaluation. Semin. Fetal Neonatal Med. 14: 101-105. http://dx.doi.org/10.1016/j.siny.2008.10.001 PMid:19167940   Pertynska-Marczewska M, Glowacka E, Sobczak M, Cypryk K, et al. (2009). Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. Am. J. Reprod. Immunol. 61: 175-182. http://dx.doi.org/10.1111/j.1600-0897.2008.00679.x PMid:19143681   Picheth G, Heidemann M, Pedrosa FO, Chautard-Freire-Maia EA, et al. (2007). The -429 T>C polymorphism of the receptor for advanced glycation end products (RAGE) is associated with type 1 diabetes in a Brazilian population. Clin. Chim. Acta 383: 163-164. http://dx.doi.org/10.1016/j.cca.2007.03.026 PMid:17512509   Schmidt AM, Hori O, Cao R, Yan SD, et al. (1996). RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45 (Suppl 3): S77-S80. PMid:8674899   Wiznitzer A, Mayer A, Novack V, Sheiner E, et al. (2009). Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am. J. Obstet. Gynecol. 201: 482-488. http://dx.doi.org/10.1016/j.ajog.2009.05.032 PMid:19631920